SDHD Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O14521 |
---|---|
Clone Names | 101008180 |
Gene ID | 6392 |
---|---|
Other Names | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial, CybS, CII-4, QPs3, Succinate dehydrogenase complex subunit D, Succinate-ubiquinone oxidoreductase cytochrome b small subunit, Succinate-ubiquinone reductase membrane anchor subunit, SDHD, SDH4 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SDHD |
---|---|
Synonyms | SDH4 |
Function | Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q). |
Cellular Location | Mitochondrion inner membrane; Multi-pass membrane protein |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Complex II of the respiratory chain, which isspecifically involved in the oxidation of succinate, carrieselectrons from FADH to CoQ. The complex is composed of fournuclear-encoded subunits and is localized in the mitochondrialinner membrane. The subunit D protein is one of two integralmembrane proteins anchoring the complex to the matrix side of themembrane. Mutations in SDHD have been linked to hereditaryparaganglioma.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Gill, A.J., et al. Hum. Pathol. 41(6):805-814(2010)Milosevic, D., et al. Clin. Biochem. 43 (7-8), 700-704 (2010) :Hermsen, M.A., et al. Cell. Oncol. 32(4):275-283(2010)Krawczyk, A., et al. Endokrynol Pol 61(1):43-48(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.